亚宝药业(600351.SH)：签订中药新药项目技术转让协议

Group 1 - The company, Yabao Pharmaceutical (600351.SH), signed a technology transfer agreement with Shanxi Traditional Chinese Medicine Research Institute on August 4, 2025 [1] - The agreement involves the acquisition of clinical trial approval, patent rights, and related technical data for a Class 1 Traditional Chinese Medicine new drug, "Chaiqin Ning Shen Granules," for a total consideration of RMB 22 million [1]